Skip to main content
Caplight Logo









CorMatrix Cardiovascular, Inc.

CorMatrix Cardiovascular, Inc.

Private
Roswell, GeorgiaHealthcare & Life Scienceshttps://corvivocardio.com/

Last Round

Growth Equity

Jul 27, 2021

Total Funding Raised

$70.6M

Company Overview

CorMatrix Cardiovascular, Inc. is a medical device company that develops and commercializes regenerative biomaterial devices for cardiovascular tissue repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

extracellular matrixECMregenerative medicinecardiovascular surgerybiomaterialtissue repairbioscaffoldcardiac implantporcine SISsmall intestinal submucosasurgical patchcardiovascular deviceimplantable envelopetissue remodelingbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CorMatrix Cardiovascular, Inc. Comparables

Compare CorMatrix Cardiovascular, Inc. with similar companies based on industry and business-model similarity.

CorMatrix Cardiovascular, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elutia Inc.
89%
Xeltis
82%
Cortex, Inc.
79%

CorMatrix Cardiovascular, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJul 27, 2021
VC RoundApr 27, 2018
StrategicMay 4, 2016
Private EquityOct 4, 2013
Private EquityOct 26, 2011
Private Equity
May 14, 2010

CorMatrix Cardiovascular, Inc. Investors

Notable investors and investment history

CorMatrix Cardiovascular, Inc. investors
InvestorRounds
Ligand PharmaceuticalsStrategic
JAM Capital PartnersGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2025

    Grew 100% QoQ, from 6 to 12 employees.

  • Jan 25, 2025

    Grew 83% QoQ, from 6 to 11 employees.

CorMatrix Cardiovascular, Inc. Filings

Explore SEC and related filing metadata, where available.

CorMatrix Cardiovascular, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CorMatrix Cardiovascular, Inc.'s valuation, stock price, and market status.

Is CorMatrix Cardiovascular, Inc. a public or private company?

CorMatrix Cardiovascular, Inc. is a private company.

What is the current stock price of CorMatrix Cardiovascular, Inc.?

CorMatrix Cardiovascular, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is CorMatrix Cardiovascular, Inc. worth (valuation)?

Valuation information for CorMatrix Cardiovascular, Inc. is not publicly available.

Can I buy CorMatrix Cardiovascular, Inc. stock?

CorMatrix Cardiovascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CorMatrix Cardiovascular, Inc.'s last funding round?

CorMatrix Cardiovascular, Inc.'s most recent funding round was Growth Equity on July 27, 2021.

Who are the main investors in CorMatrix Cardiovascular, Inc.?

Key investors in CorMatrix Cardiovascular, Inc. include Ligand Pharmaceuticals, JAM Capital Partners.

Will CorMatrix Cardiovascular, Inc. IPO soon?

No public IPO plans have been announced for CorMatrix Cardiovascular, Inc..

How can I track CorMatrix Cardiovascular, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CorMatrix Cardiovascular, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRoswell, Georgia
Employee Range14
Year Founded2001
Last FundingJul 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?